![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Range of NGS tests, based on Clinical and Whole Exome Sequencing.
Choice of target genes number and different turnaround times, according to diagnostic requirements.
Range of tests using microarray CGH, for the diagnosis of cromosomal alterations.
Indicated for mental/development retardation, congenital malformation, autism spectrum disorder or clinical picture of a specific cromosomal syndrome.
Non invasive, hight sensitivity test for detection of cell-free circulating tumor DNA (ctDNA) in the patient's bloodstream.
It allows to adapt the treatment and monitor the tumor's progression. Panels for breast, lung and colon cancer.
NGS sequencing panels for molecular confirmation and typing of epilepsy.
Bioarray's most comprehensive panel targets 543 genes linked to epilepsy.
The fast development of diagnostic techniques applied to the study of genetically based human pathologies over the past decade has made it possible to reliably study these pathologies...
The carrier screening panel is a genetic test that simultaneously analysis mutations in 298 genes which cause recessive inherited pathologies.